CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Open-market buy Director bought 78,788 shares at an average $0.86 ($67,750)
- 4 Open-market buy Chief Executive Officer bought 55,000 shares at an average $0.89 ($48,824)
- 4 Conversion Director acquired 2,751,148 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 3,120,064 shares (other)
- 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 3,330 shares at $0.81 ($2,711)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 262,500 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 445,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 337,500 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 226,105 shares at $0.45 ($101,747)
Page 6 of 10 · 187 filings